Blog Archive
-
▼
2008
(66)
-
▼
March
(8)
- ExonHit : EHT 0202 Counters Scopolamine's Detrimen...
- Mauna Kea Technologies, a leader in in-vivo cellul...
- IMSTAR : point mutation detection on DNA microarray
- Fovea Pharmaceuticals : Orphan Drug Designation fr...
- Air Liquide, First anesthesia with LENOXe
- Sanofi Pasteur , FDA Licenses DAPTACEL® Vaccine fo...
- TcLand Expression : creation of CIMNA, a unique in...
- Polyplus-transfection, GMP-quality clinical batch ...
-
▼
March
(8)
Wednesday, March 26, 2008
IMSTAR : point mutation detection on DNA microarray
06.02.2008 - IMSTAR is co-author of an article published in the current issue of BioTechnique. This work, entitled "A highly specific microarray method for point mutation detection" has been performed in collaboration with the team of Franck Sturtz at the Department of Biochemistry & Molecular Genetics of the university of Limoges (France), the Department of Neurology at the University Hospital in Limoges, the ESPCI/INSERM in Paris and Serial Genetics company in Evry... IMSTAR 's Press Release -